423 studies found for:    Open Studies | Exclude Unknown | "heart disease"OR"stroke"OR"cardiovascular disease" | United States | Phase 1, 2, 3, 0 | Industry
Show Display Options
Rank Status Study
21 Recruiting BOTOX® Treatment in Pediatric Upper Limb Spasticity
Conditions: Pediatrics;   Muscle Spasticity;   Cerebral Palsy;   Stroke
Interventions: Biological: botulinum toxin Type A;   Drug: Normal Saline (Placebo)
22 Recruiting BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
Conditions: Pediatrics;   Muscle Spasticity;   Cerebral Palsy;   Stroke
Intervention: Biological: botulinum toxin Type A
23 Recruiting OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity
Conditions: Muscle Spasticity;   Stroke
Interventions: Biological: onabotulinumtoxinA;   Drug: placebo (normal saline)
24 Not yet recruiting Long-Term Study of OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity
Conditions: Muscle Spasticity;   Stroke
Intervention: Biological: onabotulinumtoxinA
25 Recruiting Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions
Conditions: Stroke;   Brain Ischemia;   Vasospasm, Intracranial;   Hemorrhage, Intracranial
Interventions: Drug: Dexmedetomidine;   Drug: Fentanyl;   Drug: Midazolam
26 Recruiting Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Comorbidities
Condition: Cardiovascular Disease
Interventions: Drug: Febuxostat;   Drug: Allopurinol
27 Recruiting The Evaluation Of PF-04950615 (RN316), In Reducing The Occurrence Of Major Cardiovascular Events In High Risk Subjects
Condition: Cardiovascular Disease
Interventions: Drug: PF-04950615;   Drug: Placebo
28 Recruiting The Evaluation Of PF-04950615 (RN316) In Reducing The Occurrence Of Major Cardiovascular Events In High Risk Subjects
Condition: Cardiovascular Disease
Interventions: Drug: PF-04950615;   Drug: Placebo
29 Recruiting Study of Botulinum Toxin and Recovery of Hand Function After Stroke
Condition: Stroke With Hemiparesis
Intervention: Drug: Botulinum Toxin commonly known as BOTOX®
30 Recruiting The Fibrin Pad CV Phase III Study
Condition: Cardiovascular Disease
Interventions: Biological: EVARREST™ Fibrin Sealant Patch;   Biological: Topical hemostat
31 Recruiting MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Condition: Acute Stroke
Intervention: Drug: IV rt-PA
32 Recruiting Safety & Efficacy of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia (ATHENA II)
Condition: Myocardial Ischemia
Interventions: Device: Adipose-Derived Regenerative Cells (ADRCs) - Celution System;   Device: Placebo - Physiological Solution
33 Recruiting Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Condition: Atherosclerotic Coronary Vascular Disease
Intervention: Drug: Ranolazine
34 Recruiting Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Condition: Ischemic Attack, Transient
Interventions: Drug: Clopidogrel;   Drug: placebo
35 Not yet recruiting Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
Condition: Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
Interventions: Drug: Epanova® (omega-3 carboxylic acids);   Drug: corn oil control
36 Recruiting Antithrombin III in Infants With Cardiopulmonary Bypass (CPB)
Condition: Congenital Heart Disease
Interventions: Drug: Antithrombin III;   Drug: Placebo
37 Recruiting A Study of the Efficacy and Safety of Activase (Alteplase) in Patients With Mild Stroke (PRISMS)
Condition: Brain Ischemia
Interventions: Drug: alteplase [Activase];   Drug: alteplase placebo;   Drug: aspirin;   Drug: aspirin placebo
38 Recruiting Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery
Conditions: Anemia;   Cardiovascular Disease
Intervention: Drug: Treatment
39 Recruiting Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events
Conditions: Diabetes Mellitus, Non-Insulin-Dependent;   High Risk for Cardiovascular Event
Interventions: Drug: Dapagliflozin 10 mg;   Drug: Placebo tablet
40 Recruiting Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation
Condition: Paroxysmal Atrial Fibrillation (PAF)
Interventions: Device: Blazer Open-Irrigated Ablation Catheter (Boston Scientific);   Device: FDA Approved Open-Irrigated Ablation Catheter

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years